Kaplan Johanne 4

What Happened
Johanne Kaplan, Chief Development Officer of ProMIS Neurosciences Inc. (PMN), reported an open-market purchase of 1,629 shares on February 19, 2026. The shares were acquired at $15.35 per share, for a total transaction value of approximately $25,005. This was a direct purchase (transaction code P), which is generally viewed as a buying/accumulation action rather than a sale.

Key Details

• Transaction date and price: 2026-02-19 — 1,629 shares at $15.35 each.
• Total value: ~$25,005.
• Filing date: 2026-02-23 (filed within the two-business-day Form 4 deadline).
• Shares owned after transaction: not disclosed in the provided filing summary.
• Footnotes/plan: no 10b5-1 plan, tax withholding, or other footnotes provided in the summary.

Context
This was a straightforward open-market purchase (P). Insider purchases can be of interest to investors as one signal of management’s conviction, though they do not guarantee future performance. The Form 4 was filed on Feb 23, which is within the required two business days after the Feb 19 transaction.